Delivery Order SPE2DB24D8001-SPE2DB25FKZLF

Award Date 3/27/25
Potential Completion Date 3/28/25
Potential Value $4.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide 4566211938 NURTEC ODT 75 MG TABLET 8S. The delivery order, valued at $11,724.07, is for a firm fixed price contract with an ultimate completion date of October 28, 2024. The contract is not set aside and is part of DLA's ECAT Generation V Program, a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that enables Dakota Drug,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $4,403.92, is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, a broader indefinite delivery contract (IDC) valued at $999,999,999.00 that allows Dakota Drug, Inc. to provide...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a ceiling value of $2,283.39 and a period of performance through April 3, 2025. Dakota Drug, Inc. is an established federal contractor, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the ECAT...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $5,399.31, is for the delivery of NURTEC ODT 75 MG TABLET 8S pharmaceutical products. The contract is a firm-fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC is part of the DLA Troop Support Medical's ECAT Generation V...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, with a ceiling value of $4,121.49, is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The award is not associated with a larger contract vehicle and does not have a set-aside designation. The contract has an ultimate completion date of January 26, 2024. Dakota Drug, Inc. is a key supplier...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S medical supplies, with a ceiling value of $13,362.48 and a period of performance through January 28, 2025. This award is not associated with a set-aside program. Dakota Drug, Inc. also holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA,...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $10,506.31 firm fixed-price delivery order is for the provision of NURTEC ODT 75 MG TABLET 8S, a prescription medication. The award is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to supply a wide range of pharmaceutical products,...
This firm fixed-price delivery order contract, valued at $14,543.54, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of the pharmaceutical product NURTEC ODT 75 MG TABLET 8S, which supports the medical supply chain operations of the U.S. Armed Forces. The contract has an ultimate completion date of June 11, 2024 and was awarded on June 10, 2024 without any set-aside...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $2,997.26, is for the delivery of NURTEC ODT 75 MG TABLET 8S and does not have a set-aside designation. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with the DLA, identified as SPE2DB24D8001 and valued at $999,999,999.00. This IDC is...
This is a $5,778.50 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The award is not associated with any larger contract vehicle and does not have a set-aside designation. Dakota Drug, Inc. has over two decades of experience as a prime contractor to the Department of Defense and DLA,...
  • SPE2DB24D8001
    Indefinite Delivery Contract
  • SPE2DB24D8001-SPE2DB25FKZLF
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a ceiling value of $4,703.61 and a period of performance through March 28, 2025.

The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, a larger indefinite delivery contract (IDC) with Dakota Drug, Inc. valued at $999,999,999.00. This IDC allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract is an unrestricted, non-set-aside award, indicating Dakota Drug, Inc.'s strong competitive position in the federal marketplace.

Generated 6/26/25, 10:17 AM